USD
+$0.00
(+0.00%
)At Close (As of Oct 13, 2025)
$139.39B
Market Cap
48.29
P/E Ratio
7.55
EPS
$403.95
52 Week High
$327.71
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $14B |
Total Revenue | $23B |
Cost Of Revenue | $8.6B |
Costof Goods And Services Sold | $8.6B |
Operating Income | $5.1B |
Selling General And Administrative | $7.7B |
Research And Development | $1.4B |
Operating Expenses | $8.9B |
Investment Income Net | - |
Net Interest Income | - |
Interest Income | $257M |
Interest Expense | $396M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $1.1B |
Income Before Tax | $3.5B |
Income Tax Expense | $499M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $3B |
Comprehensive Income Net Of Tax | - |
Ebit | $3.9B |
Ebitda | $4.9B |
Net Income | $3B |
Field | Value (USD) |
---|---|
Total Assets | $43B |
Total Current Assets | $15B |
Cash And Cash Equivalents At Carrying Value | $3.7B |
Cash And Short Term Investments | $3.7B |
Inventory | $4.8B |
Current Net Receivables | $4B |
Total Non Current Assets | $28B |
Property Plant Equipment | $4B |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $4.4B |
Intangible Assets Excluding Goodwill | $4.4B |
Goodwill | $16B |
Investments | - |
Long Term Investments | - |
Short Term Investments | $750M |
Other Current Assets | $1.7B |
Other Non Current Assets | - |
Total Liabilities | $22B |
Total Current Liabilities | $7.6B |
Current Accounts Payable | $1.7B |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $1.4B |
Total Non Current Liabilities | $15B |
Capital Lease Obligations | - |
Long Term Debt | $12B |
Current Long Term Debt | $1.4B |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $1.4B |
Other Current Liabilities | $4B |
Other Non Current Liabilities | $2.2B |
Total Shareholder Equity | $21B |
Treasury Stock | - |
Retained Earnings | $19B |
Common Stock | $38M |
Common Stock Shares Outstanding | $386M |
Field | Value (USD) |
---|---|
Operating Cashflow | $4.2B |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $1.1B |
Capital Expenditures | $755M |
Change In Receivables | - |
Change In Inventory | -$206M |
Profit Loss | - |
Cashflow From Investment | -$3B |
Cashflow From Financing | -$525M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | $1.2B |
Dividend Payout Common Stock | $1.2B |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | -$195M |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | $3B |
Field | Value (USD) |
---|---|
Gross Profit | $14B |
Total Revenue | $23B |
Cost Of Revenue | $8.6B |
Costof Goods And Services Sold | $8.6B |
Operating Income | $5.1B |
Selling General And Administrative | $7.7B |
Research And Development | $1.4B |
Operating Expenses | $8.9B |
Investment Income Net | - |
Net Interest Income | - |
Interest Income | $257M |
Interest Expense | $396M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $1.1B |
Income Before Tax | $3.5B |
Income Tax Expense | $499M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $3B |
Comprehensive Income Net Of Tax | - |
Ebit | $3.9B |
Ebitda | $4.9B |
Net Income | $3B |
Field | Value |
---|---|
Ex Dividend Date | 2025-09-30 |
Declaration Date | 2025-08-07 |
Record Date | 2025-09-30 |
Payment Date | 2025-10-31 |
Amount | 0.84 |
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
Stryker Corporation is a leading global medical technology company headquartered in Kalamazoo, Michigan, renowned for its innovative solutions in the healthcare sector. The company specializes in a diverse range of products, including joint replacement implants, surgical equipment, and advanced navigation systems, as well as patient handling and emergency medical devices. With a strong commitment to enhancing patient care across multiple specialties such as orthopedics, neurosurgery, and emergency medicine, Stryker leverages cutting-edge technology to improve surgical outcomes and streamline healthcare processes. Its robust portfolio positions Stryker as a key player in the rapidly evolving medical device industry, making it an attractive investment opportunity for institutional investors.